Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

1993 • 716 citations

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.

1994 • 639 citations

Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete Remission

1995 • 513 citations

Creatinine Clearance: Bedside Estimate

1973 • 489 citations

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.

1995 • 302 citations

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.

1994 • 252 citations

Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.

1990 • 217 citations

Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study.

1995 • 178 citations

Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial

1989 • 170 citations

Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.

1990 • 161 citations

Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer.

1995 • 161 citations

Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer

1989 • 104 citations

Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party

1989 • 89 citations

Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.

1994 • 88 citations

Paclitaxel administered by 1-hour infusion. Preliminary results of a phase 1/11 trial comparing two schedules

1994 • 55 citations

The activity of 10-, 14-, and 21-day schedules of single-agent etoposide in previously untreated patients with extensive small cell lung cancer.

1992 • 51 citations

Phase II and III studies with carboplatin in small cell lung cancer.

1992 • 16 citations

Paclitaxel administered by a 1-hour infusion: A phase I-II trial comparing two schedules.

1995 • 13 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...